Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer

Miyawaki, M; Yasuda, H; Tani, T; Hamamoto, J; Arai, D; Ishioka, K; Ohgino, K; Nukaga, S; Hirano, T; Kawada, I; Naoki, K; Hayashi, Y; Betsuyaku, T; Soejima, K

Soejima, K (reprint author), Keio Univ, Sch Med, Dept Med, Div Pulm Med,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.; Yasuda, H (reprint author), Keio Univ, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.

MOLECULAR CANCER RESEARCH, 2017; 15 (1): 106

Abstract

Activation of the EGFR pathway is one of the mechanisms inducing acquired resistance to anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (T......

Full Text Link